Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Medical Wire and Equipment company’s Sigma MM inactivates SARS-CoV-2 in 60 seconds, preserving the RNA for safe transportation and testing
, /in Product News /by panglobalThere have been many clinical studies carried out on Sigma MM over the years to prove that it not only inactivates infectious pathogens in 60 seconds, but also preserves the DNA and RNA for safe transportation of samples for at least 21 days at room and refrigerated temperatures.
Euroimmun enables globally connected IIFT diagnostics
, /in Product News /by panglobalEuroimmun has launched EUROLabPolaris, a multisite platform for global transfer and central evaluation of indirect immuno-fluorescence (IIFT) data. The software supports laboratories that can process IIFT, but cannot diagnostically evaluate the results, for example due to a lack of staff with experience in immunofluorescence diagnostics.
Greiner Bio-One’s VACUETTE FC Mix tube provides glucose stabilization from the start
, /in Product News /by panglobalGreiner Bio-One’s VACUETTE FC Mix Tube is the ideal tool for reliably detecting diabetes and taking appropriate measures to combat the condition.
Finnish diagnostics pioneers Abacus Diagnostica, Kaivogen and Labrox join to form Uniogen
, /in E-News /by panglobalThree Finnish life science experts – Abacus Diagnostica, a frontrunner in molecular testing and rapid PCR test systems, Kaivogen, a specialist in immunoassays and antibody tests, and Labrox, an innovator of high technology laboratory instruments and diagnostic readers – have joined forces to form a global diagnostics pioneer. The name of the new company is […]
Selux Diagnostics raises additional $50 million in Series C funding round
, /in E-News /by panglobalSelux Diagnostics, which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform.
Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies
, /in E-News /by panglobalOrbit Discovery, a ground-breaking peptide discovery company, and WuXi AppTec, a leading provider of R&D and manufacturing services for the pharmaceutical and healthcare industries, have formed a partnership wherein Orbit will combine its leading peptide discovery platform and experience with WuXi AppTec’s down-stream capabilities.
MolGen showcases high throughput testing, industry systems, reagents, consumables and complete workflows at SLAS 2022
, /in E-News /by panglobalMolGen showcased its high-tech laboratory automation technology, customized diagnostic workflow and its latest products and services to technology professionals and life science researchers at SLAS 2022 in Boston, US, in February. MolGen displayed its complete diagnostics workflow and molecular automation product offerings for human diagnostics and pharmaceutical sciences that are available worldwide.
ProBioGen signs commercial license agreement with AstraZeneca providing their GlymaxX technology
, /in E-News /by panglobalProBioGen has inked a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology.
Evonetix demonstrates novel enzymatic DNA synthesis method
, /in E-News /by panglobalEvonetix, the synthetic biology company bringing semiconductor technology to DNA synthesis, has achieved enzymatic DNA synthesis capability with its proprietary, thermally controlled synthesis chemistry. The culmination of a three-year development programme, supported by Innovate UK and in collaboration with Durham University, the results demonstrate that Evonetix’s unique, semi- conductor array-based platform is compatible with both […]
Centauri Therapeutics raises £24 million to advance anti-microbial resistance research
, /in E-News /by panglobalCentauri Therapeutics, an immunotherapy company founded by Animatrix Founders LLP and focused on the treatment of infectious diseases, has closed a £24 million (US$32 million) Series A investment round. The funds will support the continued advancement of the company’s antimicrobial resistance (AMR) research and development, using the Alphamer platform to identify and progress novel antibacterial […]